Legend Biotech Corp ADR (NASDAQ:LEGN) price on current trading day, fall -1.32% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $43.62.
A look at the stock’s price movement, the level at last check in today’s session was $44.21, moving within a range at $43.14 and $44.16. The beta value (5-Year monthly) was 0.194. Turning to its 52-week performance, $60.87 and $27.34 were the 52-week high and 52-week low respectively. Overall, LEGN moved 30.50% over the past month.
Legend Biotech Corp ADR’s market cap currently stands at around $8.03 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-May-13.
Turning to the stock’s technical picture we see that short term indicators suggest on average that LEGN is a 100% Buy. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
11 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 11 recommend LEGN as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
LEGN’s current price about 10.39% and 24.86% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 72.61, while 7-day volatility ratio is 3.89% and 4.39% in the 30-day chart. Further, Legend Biotech Corp ADR (LEGN) has a beta value of 0.28. Analysts have given the company’s stock an average 52-week price target of $64.5, forecast between a low of $54 and high of $75. Looking at the price targets, the low is -23.8% off recent price level in today’s trading while to achieve the yearly target high, it has to move -71.94%. Nonetheless, investors will most likely welcome a -47.87% jump to $64.5 which is the analysts’ median price.
If we refocus on Legend Biotech Corp ADR (NASDAQ:LEGN), historical trading data shows that trading volumes averaged 1.53 over the past 10 days and 1.77 million over the past 3 months. The company’s latest data on shares outstanding shows there are 184.03 million shares.
The 1.44% of Legend Biotech Corp ADR’s shares are in the hands of company insiders while institutional holders own 46.26% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 8.39 million on 2025-07-15, giving us a short ratio of 5.58. The data shows that as of 2025-07-15 short interest in Legend Biotech Corp ADR (LEGN) stood at 874.0 of shares outstanding, with shares short falling to 14.37 million registered in 2025-06-13. Current price change has pushed the stock -27.15% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the LEGN stock continues to rise going into the next quarter.
